Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.

Santen, R J; Petroni, G R; Fisch, M J; Myers, C E; Theodorescu, D; Cohen, R B

Santen, R J; Petroni, G R; Fisch, M J; Myers, C E; Theodorescu, D; Cohen, R B.

Affiliation

Santen RJ; Department of Medicine, University of Virginia Health System, Charlottesville, Virginia 22908, USA. rjs5y@virginia.edu

Cancer ; 92(8): 2095-101, 2001 Oct 15.

Article in En | MEDLINE | ID: mdl-11596025

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Aromatase Inhibitors; Enzyme Inhibitors/therapeutic use; Nitriles/therapeutic use; Prostatic Neoplasms/drug therapy; Triazoles/therapeutic use; Aged; Aged, 80 and over; Anastrozole; Humans; Male; Middle Aged; Pain Measurement; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Triazoles / Antineoplastic Agents, Hormonal / Aromatase Inhibitors / Enzyme Inhibitors / Nitriles Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2001 Document type: Article

Search on Google

XML

PubMed Links